A New Target for Chronic Pain: Halting Microglial Pruning in the Brain
Research published in Experimental & Molecular Medicine reveals a novel brain mechanism underlying chronic muscle pain (CMP). Using a rat model, scientists found that reduced neuronal activity in the dorsomedial prefrontal cortex (dmPFC) is linked to CMP and associated anxiety. This hypoactivity is caused by microglial cells—the brain’s immune sentinels—excessively pruning synapses via the CR3 receptor pathway, leading to glutamatergic dysfunction. Crucially, the study demonstrated that chemogenetic or optogenetic restoration of neuronal activity in the dmPFC alleviated both pain and anxiety behaviors. This positions microglial-mediated synaptic pruning as a potential new therapeutic target, moving beyond symptomatic relief to address a central neural cause of chronic pain.
Why it might matter to you: For anesthesiologists and pain medicine specialists, this research suggests a paradigm shift from purely modulating pain signals to potentially modifying the brain’s maladaptive immune response. Understanding this microglial mechanism could inform the development of future adjuvant therapies for complex regional pain syndromes or postoperative pain that transitions to chronicity. It highlights the importance of central nervous system plasticity in pain persistence, a factor that extends beyond the traditional focus of regional anesthesia and nerve blocks.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.